Intragastric Balloons in the Management of Obesity

Publication Date: March 31, 2021

Key Points

Key Points

  • Obesity is a global pandemic, affecting about 40% of adults in the United States.
  • Fewer than 5% of patients with obesity seeking a weight loss therapy are aware of endoscopic weight loss options.
  • Multiple new devices have recently been introduced into the U.S. market

Treatment

Treatment

...dividuals with obesity seeking a weight-loss inter...


...s with obesity undergoing IGB ther...


...ndividuals undergoing IGB therapy, AGA recommen...


...dividuals undergoing IGB therapy, AGA suggest...


...In individuals undergoing IGB therapy, AGA sugg...


...daily supplementation with 1–2 adult dose...


...removal, AGA suggests subsequent weight-loss...